Time and venue yet to be confirmed.
Evaluation of the program and final reflections. Guest speaker from earlier Mentorship Program on what’s next.
For more information about the Swedish Chamber of Commerce and Young Professionals Mentorship Program 2019-2020 please visit our even page: https://swedishchamber.nl/event-series/mentorship-program/
The Mentorship Program is made possible by the Swedish Chamber of Commerce and Mercuri Urval sponsored by
Inter IKEA Systems and Handelsbanken.
Photo by Melker Dahlstrand/Imagebank.sweden.se
Business Women Program 2020 – Session 4: More information tba.
About the Swedish Chamber of Commerce Women Business Leadership Program 2020
As an ambitious hardworking goal-oriented businesswoman we invite you to participate in Swedish Chamber of Commerce’s Business Women Leadership Program 2020 to elevate your greatness. We know that coming together in a group with like minded people increases the inspiration and motivation to take the action steps needed.
The sessions will provide the tools and guidance for you to move forward and develop an effortless kind of leadership that gives you the inspiration and energy you want in your everyday life.
This year’s focus is HEALTH!
Example of Topics that will be discussed:
This is the final date for the Swedish Chamber Woman Leadership Program this year.
Time: 10.00 – 11.00 CET
The Swedish Chamber of Commerce have the pleasure of inviting you to a Business Webinar on October 28, 2020 about AstraZeneca’s reponse to COVID.
The COVID-19 pandemic is placing immediate challenges on our healthcare systems and will also have a longer lasting impact on the way we live and think about our health – and that of others – in the years to come. As ever, AstraZeneca prioritizes the needs of patients to help ensure their safety and continued access to care. In addition, AstraZeneca plays their part in helping to relieve the pressure on healthcare systems during this critical period as well as our future recovery. Ilse van Hensbeek, medical director of AstraZeneca Netherlands, will elaborate on AstraZeneca’s response to COVID, and the efforts that entails. In addition to partnering with the University of Oxford to deliver a working vaccine, AstraZeneca researches monoclonal antibody combinations as well as the use registered treatment to combat the severe complications of the virus.
10.05 Introduction AstraZeneca by Ad Antonisse, Director Market Access & External Affairs
10.20 Progress and challenges Corona Virus by Ilse van Hensbeek, Medical Director AstraZeneca
10.55 Thank you by Swedish Chamber
11.00 End of Webinar
Thank you for registering for this event. Below you can let us know if you want to bring a guest, and if so, how many.